China approves new treatment for myasthenia gravis
October 25, 2026
Important Health - What Actually Matters
Risk Factors
Cancer Drug Makers Face Logistics Crisis After NPPA Order
October 26, 2026
Cancer drug manufacturers confront a logistics crisis following the NPPA's TMR order, causing operational challenges and compliance issues.
READ THE ARTICLE 
India Supreme Court questions drug price markups
October 24, 2026
Pharmacists seek role in health standards revision
October 23, 2026
Indian hospitals back mandatory price transparency rules
October 22, 2026
RISK FACTORS
Cancer Drug Makers Face Logistics Crisis After NPPA Order
Cancer drug manufacturers confront a logistics crisis following the NPPA's TMR order, causing operational challenges and compliance issues.
India Supreme Court questions drug price markups
India Supreme Court questions high markups of life-saving cancer drugs and pharmaceutical prices.
The FDA has finalized its guidance on written responses and meeting types, revising circumstances for INTERACT meetings under...
Peptides face metabolic stability challenges in treating diseases like obesity and cardiovascular disorders with peptide therapeutics.
Health data utilities (HDUs) are becoming essential infrastructure for public health, education, and rural care coordination at Civitas...
UNC researchers test doulas and alerts to improve Black maternal health outcomes in a major $10 million study...
All Post
Cancer Drug Makers Face Logistics Crisis After NPPA Order
Cancer drug manufacturers confront a logistics crisis following the NPPA's TMR order, causing operational challenges and compliance issues.
China approves new treatment for myasthenia gravis
China approves new treatment for myasthenia gravis: batoclimab injection for adult patients with generalized myasthenia gravis.
India Supreme Court questions drug price markups
India Supreme Court questions high markups of life-saving cancer drugs and pharmaceutical prices.
Pharmacists seek role in health standards revision
Pharmacists seek role in health standards revision, citing gaps in current guidelines regarding pharmacists' roles.
Indian hospitals back mandatory price transparency rules
Indian hospitals back mandatory price transparency rules to boost accountability, patient trust, and cost clarity for consultations, tests, and treatments.
FDA approves HIV drug for newborns weighing 2 kg
FDA approval of ViiV Healthcare’s Tivicay PD lets HIV drug newborns as light as 2 kg receive treatment, expanding pediatric...
Roche, Hansoh Partner to Develop Cancer Therapies with $400M Deal
Roche and Hansoh Pharma partner in a $400M deal to develop cancer therapies using antibody-drug conjugate technology.
Tech giants’ R&D spending nears pharma giants’ total
Tech R&D spending hit $118.5 billion in 2025, just under the $123.7 billion total of the ten largest drugmakers, showing...
FDA launches new rare disease review framework
FDA's rare disease framework, unveiled on Oct. 14, offers a review process to standardize expectations and cut uncertainty for sponsors...
PharmSci conference adds new research tracks
AAPS launches new research tracks at PharmSci 360, exploring scientific research integrity in AI era and emerging drug development technologies.